Venture capital firm based in London, UK
BioOrbit secures £9.8m to make antibody therapies self‑injectable via microgravity crystallisation. Read more
Outpost Bio lands £2.6m pre-seed to predict drug-microbiome interactions via automated labs. Read more
Sidekick raises £7.8m to unlock private-banking investments via Lombard lending, private markets. Read more
AI compliance platform Umony raises £11.16m led by Notion Capital with SeedCamp. Umony's communications compliance platform combines AI models and regulatory expertise to detect misconduct in real time. Read more
9fin's groundbreaking $50 million Series B funding revolutionizes financial analytics with AI-powered tools, positioning the London-based platform as a leader in the competitive US market. Read more
Sable Bio secures £1.5 million funding to revolutionize drug target safety evaluation with their AI-enhanced platform, offering substantial cost and time savings in drug development, ultimately delivering safer drugs to patients faster. Read more
London-based finance platform Orbital raises £5M ($6.4M) in funding to expand its services, offering global enterprises seamless integration of stablecoins and cryptocurrencies for cross-border payments, all while eliminating the need for physical presence or domestic bank accounts. Read more
| Fintech | 53.8% |
| Biotech | 23.1% |
| HRTech | 7.7% |
| Healthtech | 7.7% |
| Legaltech | 7.7% |